From: Metabolic abnormalities in patients with prolactinoma: response to treatment with cabergoline
Parameter | Cases (n = 19) | Controls (n = 20) | P value |
---|---|---|---|
Agea | 27.3 (6.2) | 27.1 (5.6) | .9 |
Gender (men:women) | 1:18 | 2:18 | |
Body weight (kg)a | 57.3 (9.5) | 60.3 (11.1) | .35 |
BMI (kg/m2)a | 24.2 (4.0) | 24.6 (3.9) | .73 |
Waist (cm)a | 85.3 (12.0) | 83.3 (7.4) | .52 |
Hip (cm)a | 91.1 (8.7) | 91.4 (9.0) | .91 |
Waist–hip ratioa | 0.94 (0.12) | 0.92 (0.09) | .68 |
Body fat (kg) | 23.4 (10.4) | 20.5 (8.3) | .69 |
Trunk fat (kg)a | 11.0 (4.2) | 9.3 (2.8) | .044 |
Fasting glucose (mmol/l)a | 4.8 (0.5) | 4.2 (0.3) | <.001 |
Fasting insulin (pmol/l) | 34.3 (54.6) | 35.9 (22.3) | .82 |
HOMA-IR | 1.1 (1.27) | 1.4 (0.59) | .64 |
Total cholesterol (mmol/l) | 4.5 (1.4) | 3.4 (1.6) | .02 |
LDL (mmol/l)a | 2.9 (0.8) | 2.1 (0.5) | .001 |
HDL (mmol/l) | 1.1 (0.3) | 1.2 (0.3) | .04 |
Triglycerides (mmol/l)a | 1.8 (0.4) | 1.4 (0.4) | .009 |
Uric acid (µmol/l)a | 297.9 (66.6) | 206.9 (75.5) | <.001 |
FSH (IU/l)a | 5.7 (2.6) | 5.8 (1.8) | .88 |
LH (IU/l)a | 5.3 (4.4) | 5.2 (1.5) | .96 |
Estradiol (pg/ml)a | 52.7 (24.3) | 85.7 (42.6) | .018 |